3.0
20 Feb 2026
Former employee, more than 1 year
Birmingham, AL
Recommend
CEO approval
Business outlook
Pros
Exposure to pharmaceutical CDMO culture.
Cons
They were lacking fundamentally in direction and science. They very much had a crunch culture that kept their difficulties hidden instead of addressing them.